Cargando…
Engineering a Therapeutic Protein to Enhance the Study of Anti-Drug Immunity
The development of anti-drug antibodies represents a significant barrier to the utilization of protein-based therapies for a wide variety of diseases. While the rate of antibody formation can vary depending on the therapeutic employed and the target patient population receiving the drug, the antigen...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313379/ https://www.ncbi.nlm.nih.gov/pubmed/35885029 http://dx.doi.org/10.3390/biomedicines10071724 |